Browse > Article

Optimization of the Lowry Method of Protein Precipitation from the H. influenzae Type b Conjugate Vaccine Using Deoxycholic Acid and Hydrochloric Acid  

Kim, Hyun-Sung (Berna Biotech Korea Corp.)
Kim, Sang-Joon (Berna Biotech Korea Corp.)
Kim, Hui-Jung (Berna Biotech Korea Corp.)
Kim, Han-Uk (Berna Biotech Korea Corp.)
Ahn, Sang-Joem (Berna Biotech Korea Corp.)
Hur, Byung-Ki (Department of Biotechnology and Bioengineering, Inha University)
Publication Information
Biotechnology and Bioprocess Engineering:BBE / v.11, no.3, 2006 , pp. 215-222 More about this Journal
Abstract
The Lowry method was used in this study to measure protein in Haemophilus influenzae type b (Hib) conjugate vaccines (polyribosylibitol phosphate-tetanus toxoid; PRP-TT) using deoxycholic acid (DOC) to induce protein precipitation. Trichloroacetic acid (TCA) did not induce precipitation adequately from the Hib conjugate bulk and the freeze-dried Hib conjugate product. Its yield was approximately 50%. The matrix structure of Hib conjugate inhibits precipitation by TCA. Although the Lowry method can be carried out without precipitation in Hib conjugate bulk when no residual impurities (adipic acid dihydrazide [ADH], 1-ethyl-3-(3-dimethylamino-propyl) carbodiimide-HCI [EDAC], phenol and cyanogens bromide [CNBr], etc.) are present, it cannot be used for Hib conjugate products that contain sucrose 8.5%, because 8.5% concentration of sucrose enhanced the protein concentration. DOC- and HCl-induced precipitation is an alternative method for evaluating the protein content of the Hib conjugate bulk and the Hib conjugate product. The precipitation was optimal with a final concentrate of 0.1% for DOC at $4^{\circ}C$ and pH 2. This Lowry method, using DOC/HCI precipitation to induce protein precipitation, was confirmed a consistent, reproducible, and valid test for proteins in Hib conjugate bulk and its freeze-dried product.
Keywords
Haemophilus influenzae type b; conjugate vaccine; deoxycholic acid precipitation; method validation; Lowry method;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Lovrien, R. and D. Matulis (2003) Assays for total protein. pp. 18-24. In: J. E. Coligan, B. M. Duun, D. W. Speicher, and P. T. Wingfield (eds.). Short Protocols in Protein Science. John Wiley & Sons, Inc. Canada
2 Hartree, E. F. (1972) Determination of protein: A modification of the Lowry method that gives a linear photometric response. Anal. Biochem. 48: 422-427   DOI   ScienceOn
3 Ward, J. (1991) Prevention of invasive Haemophilus influenzae type b disease: lessons from vaccine efficacy trials. Vaccine 9 Suppl: S17-S24   DOI   ScienceOn
4 Pittman, M. (1933) The action of type-specific Haemophilus influenzae antiserum. J. Exp. Med. 58: 683-706   DOI
5 Onodera, M. (2002) Silicone rubber membrane bioreactors for bacterial cellulose production. Biotechnol. Bioprocess Eng. 7: 289-294   DOI   ScienceOn
6 Dajani, A. S., B. I. Asmar, and M. C. Thirumoorthi (1979) Systemic Haemophilus influenzae disease: an overview. J. Pediatr. 94: 355-364   DOI
7 Lei, Q. P., D. H. Lamb, R. Heller, and P. Pietrobon (2000) Quantitation of low level unconjugated polysaccharide tetanus toxoid-conjugate vaccine by HPAEC/PAD following rapid seperation by deoxycholate/HCl. J. Pharm. Biomed. Anal. 21: 1087-1091   DOI   ScienceOn
8 Tarr, P. I. and G. Peter (1978) Demographic factors in the epidemiology of Haemophilus influenzae meningitis in young children. J. Pediatr. 92: 884-888   DOI
9 Landsteinder, K. (1962) The Specificity of Serologic Reactions. Cambridge, Harvard University Press, Dover Publications, New York, NY, USA
10 Todd, J. K. and F. W. Bruhn (1975) Severe Haemophilus influenzae infections. Am. J. Dis. Child. 129: 607-611   DOI
11 Bae C. S., S. S. Hong, S. J. Ahn, Y. S. Jang, and B. K. Hur (2005) Importance of the degree of antigen polymerization by detoxification in modulating the immunogenicity of acellular pertussis vaccine. Biotechnol. Bioprocess Eng. 10: 230-235   과학기술학회마을   DOI   ScienceOn
12 Peterson, G. L. (1983) Determination of total protein. Meth. Enzymol. 91: 95-121   DOI
13 Granoff, D. M. and M. Basden (1980) Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J. Infect. Dis. 141: 40-46   DOI   ScienceOn
14 Coulehan, J. L., R. H. Michaels, K. E. Williams, D. K. Lemley, C. Q. North, Jr., T. K. Welty, and K. D. Rogers (1976) Bacterial meningitis in Navajo Indians. Public Health Rep. 91: 464-468
15 Guo, Y.-Y., R. Anderson, J. McIver, R. K. Gupta, and G. R. Siber (1998) A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine. Biologicals 26: 33-38   DOI   ScienceOn
16 Tsai, C.-M., X.-X. Gu, and R. A. Byrd (1994) Quantification of polysaccharide in Haemophilus influenzae type b conjugate and polysaccharide vaccines by high-performance anion-exchange chromatography with pulsed amperometric detection. Vaccine 12: 700-706   DOI   ScienceOn
17 Smith, P. K., R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk (1985) Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85   DOI   ScienceOn
18 Barrett, D. J. (1985) Human immune responses to polysaccharide antigens: an analysis of bacterial polysaccharide vaccines in infants. Adv. Pediatr. 32: 139-158
19 Guidance for Industry, Biological Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001, BP
20 Guidance for Industry, Q2B Validation of Analytical Procedure: Methodology, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), November 1996, ICH
21 Annand, R. and P. L. Romeo (1976) Protein in food stuffs. Am. Lab. 8: 37-46
22 Kim, H. S., T. H. Yoo, Y. S. Jang, H. Kim, J. Y. Park, B. K. Hur, Y. W. Ryu, and J. S. Kim (2004) An animal model to evaluate the protective efficacy of Haemophilus influenzae type b conjugate vaccines. Biotechnol. Bioprocess Eng. 9: 490-494   DOI   ScienceOn
23 Markwell, M. A., S. M. Haas, N. E. Tolbert, and L. L. Bieber (1981) Protein determination in membrane and lipoprotein samples; manual and automated procedures. Meth. Enzymol. 72: 296-303   DOI
24 Yoo, T. H., H. S. Kim, S. S. Park, E. Y. Bang, Y. K. Oh, L. S. Kim, H. Kim, B. K. Hur, Y. W. Ryu, and J. S. Kim (2003) Measurement of free polysaccharide in tetanus toxoid-conjugate vaccine using antibody/ammonium sulfate precipitation. J. Microbiol. Biotechnol. 13: 469-472
25 Dick, W. E. and J. M. Beurret (1989) Glycoconjugates of bacterial carbohydrate antigens: A survey and consideration of design and preparation factors. pp. 48-113. In: J. M. Cruse and R. E. Lewis (eds.). Conjugate Vaccines Contrib. Microb. Immunol. Karger, Switzerland
26 Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
27 Peterson, G. L. (1979) Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr, and Randall. Anal. Biochem. 100: 201-220   DOI   ScienceOn
28 Beyer, R. E. (1983) A rapid biuret assay for protein of whole fatty tissues. Anal. Biochem. 129: 483-485   DOI   ScienceOn
29 Cochi, S. L., C. V. Broome, and A. W. Hightower (1985) Immunization of US children with Haemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. J. Am. Med. Ass. 253: 521-529   DOI
30 Korea Minimum Requirements of Biological Products (1999) Haemophilus influenzae Type b-Tetanus Toxoid Conjugate Vaccine. pp. 181-190. Korea Food & Drug Administration (KFDA), Seoul, Korea